In contrast, BRCA1 associated cancers characterized as TRβ positive presented a significantly higher five-year survival rate as compared to TRβ-negative patients (p = 0.007), while TRβ failed to be of prognostic significance in sporadic breast cancer. This evidence concerns the gene THRB and breast carcinoma.